CN106421749A - 包括酪蛋白衍生肽的药物组合物及其使用方法 - Google Patents

包括酪蛋白衍生肽的药物组合物及其使用方法 Download PDF

Info

Publication number
CN106421749A
CN106421749A CN201610544021.9A CN201610544021A CN106421749A CN 106421749 A CN106421749 A CN 106421749A CN 201610544021 A CN201610544021 A CN 201610544021A CN 106421749 A CN106421749 A CN 106421749A
Authority
CN
China
Prior art keywords
casein
peptide
item
cows
milk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610544021.9A
Other languages
English (en)
Chinese (zh)
Inventor
乔斯·马里奥·伊斯柯维奇
尼西姆·斯拉尼科夫
贾维尔·伊斯柯维奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mileutis Ltd
Agricultural Research Organization
Original Assignee
Mileutis Ltd
Agricultural Research Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mileutis Ltd, Agricultural Research Organization filed Critical Mileutis Ltd
Priority claimed from CN200680024162.2A external-priority patent/CN101247721B/zh
Publication of CN106421749A publication Critical patent/CN106421749A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN201610544021.9A 2005-05-02 2006-05-02 包括酪蛋白衍生肽的药物组合物及其使用方法 Pending CN106421749A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US67629205P 2005-05-02 2005-05-02
US60/676,292 2005-05-02
US68869705P 2005-06-09 2005-06-09
US60/688,697 2005-06-09
CN200680024162.2A CN101247721B (zh) 2005-05-02 2006-05-02 包括酪蛋白衍生肽的药物组合物及其使用方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN200680024162.2A Division CN101247721B (zh) 2005-05-02 2006-05-02 包括酪蛋白衍生肽的药物组合物及其使用方法

Publications (1)

Publication Number Publication Date
CN106421749A true CN106421749A (zh) 2017-02-22

Family

ID=37308387

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610544021.9A Pending CN106421749A (zh) 2005-05-02 2006-05-02 包括酪蛋白衍生肽的药物组合物及其使用方法

Country Status (18)

Country Link
US (2) US7968513B2 (https=)
EP (1) EP1890720B1 (https=)
JP (1) JP5247429B2 (https=)
KR (2) KR20130122979A (https=)
CN (1) CN106421749A (https=)
AR (1) AR059462A1 (https=)
AU (1) AU2006242842B2 (https=)
BR (1) BRPI0611301A2 (https=)
CA (1) CA2607155C (https=)
CL (1) CL2011000039A1 (https=)
EA (1) EA016039B1 (https=)
ES (1) ES2400511T3 (https=)
IN (1) IN2014DN10391A (https=)
MX (1) MX2007013866A (https=)
NZ (1) NZ563936A (https=)
PL (1) PL1890720T3 (https=)
UY (1) UY29515A1 (https=)
WO (1) WO2006117784A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ563936A (en) * 2005-05-02 2010-03-26 Mileutis Ltd Pharmaceutical compositions comprising casein derived peptides and methods of use thereof in decreasing dry period of lactation cycle in cows and increasing milk production
KR101033818B1 (ko) * 2008-06-30 2011-05-13 조아제약주식회사 돼지의 알파에스 1 카제인 유전자, 그 프로모터 및 그의 용도
US8133916B1 (en) 2009-03-10 2012-03-13 Amelgo, LLC Control of milk production and mammary involution
US20110017323A1 (en) * 2009-07-22 2011-01-27 Ewa Herbst Method and apparatus for inline testing
WO2011132191A1 (en) 2010-04-21 2011-10-27 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections
FR2971423B1 (fr) * 2011-02-15 2014-01-10 Ceva Sante Animale Composition veterinaire antiprolactinique destinee aux ruminants
US9487557B2 (en) 2012-03-19 2016-11-08 Mileutis Ltd. Peptides for management of lactation
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins
AU2017358060B2 (en) * 2016-11-09 2023-05-04 Charles Sturt University Livestock supplement and use thereof
WO2018108975A1 (en) * 2016-12-13 2018-06-21 Dsm Ip Assets B.V. Pufa salt formulations (i)
CN108017709B (zh) * 2017-12-12 2020-04-10 浙江辉肽生命健康科技有限公司 一种生物活性多肽kepmigvnqela及其制备方法和应用
WO2021168343A2 (en) * 2020-02-19 2021-08-26 Perfect Day, Inc. Hypoallergenic recombinant milk proteins and compositions comprising the same
JP2025537820A (ja) * 2022-11-17 2025-11-20 ミレウティス リミテッド． 乳房の障害および状態を調節するための組成物および方法
MX2025013554A (es) * 2023-05-16 2026-02-03 Mileutis Ltd Mejora de la calidad de la leche

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391849B1 (en) * 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
CN1496368A (zh) * 2001-03-09 2004-05-12 明治制果株式会社 免疫增强剂
US6780844B1 (en) * 1997-03-13 2004-08-24 The University Of Melbourne Calcium phosphopeptide complexes

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
US5405756A (en) * 1982-03-30 1995-04-11 Meiji Seika Kaisha, Ltd. Transparent acid drink containing acid-soluble casein phosphopeptide
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
CA2108678C (en) * 1991-04-19 2002-09-10 Eric C. Reynolds Production of phosphopeptides from casein
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
EP1206911A4 (en) 1999-08-24 2003-01-22 Meiji Seika Kaisha GROWTH-SUPPORTING COMPOSITIONS FOR MAMMALS AND METHOD FOR PROMOTING THE GROWTH OF MAMMALS USING THE SAME
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
EA200601575A1 (ru) 2004-03-01 2007-06-29 Пептера Фармасьютикалс Лтд. Казеиновые пептиды и их терапевтическое применение
NZ563936A (en) * 2005-05-02 2010-03-26 Mileutis Ltd Pharmaceutical compositions comprising casein derived peptides and methods of use thereof in decreasing dry period of lactation cycle in cows and increasing milk production

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780844B1 (en) * 1997-03-13 2004-08-24 The University Of Melbourne Calcium phosphopeptide complexes
US6391849B1 (en) * 1999-11-19 2002-05-21 Agricultural Research Organization, The Volcani Center Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis
CN1496368A (zh) * 2001-03-09 2004-05-12 明治制果株式会社 免疫增强剂

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHAMAY A ET AL.: "Infusions of casein hydrolyzates into the mammary gland disrupt tight junction integrity and induce involution in cows", 《JOURNAL OF DAIRY SCIENCE》 *

Also Published As

Publication number Publication date
EP1890720A2 (en) 2008-02-27
WO2006117784A3 (en) 2009-05-22
KR101340676B1 (ko) 2013-12-18
BRPI0611301A2 (pt) 2010-08-31
US20110212886A1 (en) 2011-09-01
US8338363B2 (en) 2012-12-25
EP1890720A4 (en) 2010-05-26
KR20130122979A (ko) 2013-11-11
EP1890720B1 (en) 2013-01-09
JP5247429B2 (ja) 2013-07-24
AU2006242842A1 (en) 2006-11-09
ES2400511T3 (es) 2013-04-10
AR059462A1 (es) 2008-04-09
NZ563936A (en) 2010-03-26
US7968513B2 (en) 2011-06-28
EA016039B1 (ru) 2012-01-30
CA2607155C (en) 2016-09-13
IN2014DN10391A (https=) 2015-08-14
JP2008540399A (ja) 2008-11-20
CL2011000039A1 (es) 2011-06-10
UY29515A1 (es) 2007-11-30
EA200702401A1 (ru) 2008-08-29
PL1890720T3 (pl) 2013-06-28
MX2007013866A (es) 2008-04-07
US20090069218A1 (en) 2009-03-12
AU2006242842B2 (en) 2011-12-08
CA2607155A1 (en) 2006-11-09
WO2006117784A2 (en) 2006-11-09
KR20080012933A (ko) 2008-02-12

Similar Documents

Publication Publication Date Title
US8338363B2 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
PT88626B (pt) Processo para a preparacao de um factor de crescimento polipeptidico proveniente de leite
JP6426599B2 (ja) 乳汁分泌の管理用のペプチド
CN101247721B (zh) 包括酪蛋白衍生肽的药物组合物及其使用方法
US20240207352A1 (en) Compositions and methods for modulating mammary disorders and conditions
AU2012200889B2 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
HK1120368A (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
IL222487A (en) Casein-derived peptides and methods for using them to increase milk yield
IL222486A (en) Casein-derived peptides and methods for using them to enhance milk cleanliness
IL187120A (en) Casein-derived peptides and methods for their use in the herd's interface with milk
AU2023380303A1 (en) Compositions and methods for modulating mammary disorders and conditions
AU2024274533A9 (en) Enhanced milk quality

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170222

RJ01 Rejection of invention patent application after publication